The Cigna Group
CI: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$531.00 | Fkhfs | Mmdhgqymp |
Cigna Earnings: Boosts 2024 Outlook Mildly as Its Unique Business Mix Shines
Narrow-moat Cigna turned in strong first-quarter results and raised its 2024 outlook a bit. At first glance, we do not anticipate changing our $366 fair value estimate, though, and we consider shares about fairly valued.